Enzon Pharmaceuticals Inc (ENZN)
0.0795
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Enzon Pharmaceuticals Price: 0.0795 for Nov. 13, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 13, 2024 | 0.076 | 0.0795 | 0.071 | 0.0795 | 4060.00 |
Nov 12, 2024 | 0.082 | 0.082 | 0.076 | 0.079 | 3032.00 |
Nov 11, 2024 | 0.084 | 0.0846 | 0.0835 | 0.0846 | 881.00 |
Nov 08, 2024 | 0.085 | 0.085 | 0.085 | 0.085 | 0.000 |
Nov 07, 2024 | 0.085 | 0.085 | 0.085 | 0.085 | 0.000 |
Nov 06, 2024 | 0.085 | 0.085 | 0.085 | 0.085 | 600.00 |
Nov 05, 2024 | 0.076 | 0.0898 | 0.076 | 0.0898 | 11678.00 |
Nov 04, 2024 | 0.09 | 0.09 | 0.0788 | 0.0788 | 2721.00 |
Nov 01, 2024 | 0.084 | 0.084 | 0.0788 | 0.0825 | 2302.00 |
Oct 31, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 1283.00 |
Oct 30, 2024 | 0.0838 | 0.0838 | 0.077 | 0.077 | 91997.00 |
Oct 29, 2024 | 0.095 | 0.095 | 0.08 | 0.09 | 13600.00 |
Oct 28, 2024 | 0.08 | 0.085 | 0.0699 | 0.08 | 137243.0 |
Oct 25, 2024 | 0.1033 | 0.1033 | 0.1001 | 0.1001 | 20100.00 |
Oct 24, 2024 | 0.1164 | 0.1164 | 0.1001 | 0.105 | 35222.00 |
Oct 23, 2024 | 0.103 | 0.105 | 0.0864 | 0.105 | 76132.00 |
Oct 22, 2024 | 0.109 | 0.109 | 0.109 | 0.109 | 100.00 |
Oct 21, 2024 | 0.1249 | 0.1249 | 0.1249 | 0.1249 | 0.000 |
Oct 18, 2024 | 0.1249 | 0.1249 | 0.1249 | 0.1249 | 554.00 |
Oct 17, 2024 | 0.1172 | 0.1172 | 0.1172 | 0.1172 | 0.000 |
Oct 16, 2024 | 0.1172 | 0.1172 | 0.1172 | 0.1172 | 0.000 |
Oct 15, 2024 | 0.11 | 0.1172 | 0.1031 | 0.1172 | 7110.00 |
Oct 14, 2024 | 0.112 | 0.12 | 0.103 | 0.11 | 14996.00 |
Oct 11, 2024 | 0.11 | 0.1249 | 0.11 | 0.1159 | 24808.00 |
Oct 10, 2024 | 0.113 | 0.1145 | 0.101 | 0.1102 | 13614.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.06
Minimum
Mar 19 2024
0.835
Maximum
Feb 08 2021
0.2614
Average
0.215
Median
Jan 02 2020
Price Benchmarks
AIM ImmunoTech Inc | 0.248 |
Perspective Therapeutics Inc | 9.13 |
Protalix BioTherapeutics Inc | 1.36 |
Electromed Inc | 28.85 |
Armata Pharmaceuticals Inc | 2.72 |
Price Related Metrics
PE Ratio | 60.73 |
Price to Book Value | 2.136 |
Price to Free Cash Flow | 4.367 |
Earnings Yield | 1.65% |
Market Cap | 5.900M |
Normalized PE Ratio | 35.96 |